Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) shares traded up 1.9% on Tuesday. The stock traded as high as $366.70 and last traded at $357.84. Approximately 2,658,819 shares changed hands during mid-day trading, a decline of 49% from the average session volume of 5,216,984 shares. The stock had previously closed at $351.31.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the stock. Jefferies Financial Group increased their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Stifel Nicolaus increased their target price on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Barclays lifted their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. Morgan Stanley boosted their price target on Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Finally, Needham & Company LLC upped their price target on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $348.33.
View Our Latest Report on Astera Labs
Astera Labs Stock Up 1.9%
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business’s revenue was up 104.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.
Insider Transactions at Astera Labs
In other Astera Labs news, Director Stefan Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total value of $963,734.80. Following the sale, the director directly owned 50,456 shares in the company, valued at approximately $13,873,381.76. This trade represents a 6.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 591,558 shares of company stock valued at $209,458,976 over the last three months. 10.40% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in Astera Labs in the second quarter worth about $6,609,581,000. Bank of America Corp DE acquired a new position in Astera Labs during the 2nd quarter valued at about $1,061,791,000. Atreides Management LP raised its position in shares of Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after buying an additional 1,754,593 shares in the last quarter. Artisan Partners Limited Partnership acquired a new stake in shares of Astera Labs in the 4th quarter worth approximately $148,980,000. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Astera Labs by 189.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after acquiring an additional 858,693 shares during the period. Institutional investors own 60.47% of the company’s stock.
About Astera Labs
Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.
The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.
See Also
- Five stocks we like better than Astera Labs
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
